CMA imposes substantial fines on pharma firms for overcharging the NHS

16th July 2021 Uncategorised 0

Competition regulator announces fines totalling £260m relating to the supply of hydrocortisone tablets

More: CMA imposes substantial fines on pharma firms for overcharging the NHS
Source: News